Letters to the Editor
Vol. 5 No. 1 (2026)
Hemophilia-free mind: a call to action
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 10 March 2026
116
Views
55
Downloads
Authors
Dear Editor,
Over the last few decades, therapeutic goals for people with hemophilia (PwH) -particularly moderate and severe forms- have undergone a remarkable transformation...
Downloads
Download data is not yet available.
Citations
1. Mannucci PM. Gene transfer in hemophilia A: not cogent yet. Bleeding Thromb Vasc Biol 2022;1:32. DOI: https://doi.org/10.4081/btvb.2022.32
2. Mannucci PM. Growing weapons to fight hemophilia. Bleeding Thromb Vasc Biol 2023;2:64. DOI: https://doi.org/10.4081/btvb.2023.64
3. Mannucci PM. Gene therapy for hemophilia B. Bleeding Thromb Vasc Biol 2025;4:425. DOI: https://doi.org/10.4081/btvb.2025.425
4. Castaman G. Gene transfer in hemophilia B: a big step forward. Bleeding Thromb Vasc Biol 2023;2:70. DOI: https://doi.org/10.4081/btvb.2023.70
5. Di Minno G, Spadarella G, Calcaterra IL, et al. The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art. Bleeding Thromb Vasc Biol 2024;3:144. DOI: https://doi.org/10.4081/btvb.2024.144
6. Krumb E, Hermans C. Living with a "hemophilia-free mind" - The new ambition of hemophilia care? Res Pract Thromb Haemost 2021;5:e12567. DOI: https://doi.org/10.1002/rth2.12567
7. Hermans C, Pierce GF. Towards achieving a haemophilia-free mind. Haemophilia 2023;29:951-3. DOI: https://doi.org/10.1111/hae.14807
CRediT authorship contribution
Tiziano Martini, Cristina Dainese, Chiara Gorio, writing - original draft. Giancarlo Castaman, Rita Carlotta Santoro, writing - review & editing.
Data Availability Statement
The research data are contained in the two studies referenced in the letter to the editor, which are publicly available on PubMed.
How to Cite
1.
Martini T, Gorio C, Dainese C, Santoro RC, Castaman G. Hemophilia-free mind: a call to action. Bleeding Thromb Vasc Biol [Internet]. 2026 Mar. 10 [cited 2026 Mar. 28];5(1). Available from: https://www.btvb.org/btvb/article/view/465
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- Silvia Linari, Renato Marino, Marzia Leotta, Antonio Coppola, Patrizia Di Gregorio, Augusto Bramante Federici, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro, The landscape of rare coagulation factor deficiency management in Italy: a national hemophilia center survey , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Sarah Gallitto, Thomas C. Varkey, Jacob Lahti, Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 3 (2024)
- Roger Lijnen, Désiré Collen, The key to fibrinolysis and thrombolysis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Stefania Cavazza, Gualtiero Palareti*, Still unmet problems with low molecular weight heparin prophylaxis of venous thromboembolism. An Italian survey , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Renato Marino, Silvia Linari, Marzia Leotta, Antonio Coppola, Chiara Biasoli, Maria Elisa Mancuso, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro, Diagnostic and management practices for inherited fibrinogen disorders: a nationwide survey of Italian Hemophilia Treatment Centers , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Pier Mannuccio Mannucci, Gene therapy for hemophilia B , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Ilaria Nichele, Giuseppe Carli, Alberto Tosetto, Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 1 (2024)
- PO86 | Emicizumab in patients with moderate hemophilia A and severe bleeding phenotype: single-center real-world experience , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO67 | Pancreatic cancer in a 71-year-old severe hemophilia A patient with inhibitors and sustained zero bleeding during emicizumab prophylaxis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
1-10 of 210
Next
You may also start an advanced similarity search for this article.
